Tariffs, Trade, and Dealmaking: Emerging Risks for Life Sciences Companies
The past year has proven tumultuous for life sciences companies, whose pharmaceutical products, active ingredients, and medical devices...
The past year has proven tumultuous for life sciences companies, whose pharmaceutical products, active ingredients, and medical devices...
As covered in our previous post, on February 20, 2026, the US Supreme Court ruled that the International Emergency Economic Powers...
On February 20, 2026, the US Supreme Court decided in Learning Resources, Inc., et al. v. Trump, that the International Emergency...
If the US Supreme Court (SCOTUS, or the Court) strikes down President Trump’s tariffs based on the International Emergency Economic...
In 2025, US litigation and enforcement risk evolved sharply for both US and foreign companies operating internationally. Recent court...
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net